> top > docs > PubMed:30969784 > annotations

PubMed:30969784 JSONTXT

Annnotations TAB JSON ListView MergeView

sonoma2

Id Subject Object Predicate Lexical cue
T0 0-10 MPA denotes Biomarkers
T1 14-37 CPA denotes Endothelial Dysfunction
T2 52-77 DISEASE denotes Polycystic Ovary Syndrome
T3 79-104 DISEASE denotes Polycystic ovary syndrome
T4 106-110 DISEASE denotes PCOS
T5 124-130 REG denotes common
T6 131-149 DISEASE denotes endocrine disorder
T7 359-386 GENE denotes adipocyte-secreted hormones
T8 424-447 CPA denotes endothelial dysfunction
T9 424-447 DISEASE denotes endothelial dysfunction
T10 451-455 DISEASE denotes PCOS
T11 590-600 MPA denotes biomarkers
T12 604-615 CPA denotes endothelial
T13 604-627 DISEASE denotes endothelial dysfunction
T14 629-637 GENE denotes visfatin
T15 629-637 GENE denotes visfatin
T16 639-647 GENE denotes vascular
T17 639-673 GENE denotes vascular endothelial growth factor
T18 648-659 GENE denotes endothelial
T19 675-679 GENE denotes VEGF
T20 682-708 GENE denotes matrix metalloproteinase 9
T21 710-715 GENE denotes MMP-9
T22 732-736 DISEASE denotes PCOS
T23 749-753 DISEASE denotes PCOS
T24 783-791 GENE denotes visfatin
T25 783-791 GENE denotes visfatin
T26 792-806 MPA denotes concentrations
T27 866-875 POSREG denotes increased
T28 876-880 GENE denotes VEGF
T29 881-891 MPA denotes production
T30 917-929 CPA denotes inflammation
T31 917-929 DISEASE denotes inflammation
T32 939-948 POSREG denotes increased
T33 949-954 GENE denotes MMP-9
T34 955-969 MPA denotes concentrations
T35 986-993 REG denotes related
T36 1025-1038 REG denotes abnormalities
T37 1025-1049 DISEASE denotes abnormalities of ovarian
T38 1042-1070 CPA denotes ovarian extracellular matrix
T39 1083-1106 CPA denotes multiple cyst formation
T40 1108-1126 CPA denotes follicular atresia
T41 1108-1126 DISEASE denotes follicular atresia
T42 1140-1151 CPA denotes anovulation
T43 1156-1160 DISEASE denotes PCOS
T44 1170-1180 REG denotes associated
T45 1219-1230 CPA denotes endothelial
T46 1219-1242 DISEASE denotes endothelial dysfunction
R41 T39 T35 ThemeOf multiple cyst formation,related
R42 T39 T36 ThemeOf multiple cyst formation,abnormalities
R43 T40 T35 ThemeOf follicular atresia,related
R44 T43 T44 ThemeOf PCOS,associated
R45 T45 T44 ThemeOf endothelial,associated
R0 T1 T0 ThemeOf Endothelial Dysfunction,Biomarkers
R1 T2 T0 ThemeOf Polycystic Ovary Syndrome,Biomarkers
R2 T2 T1 ThemeOf Polycystic Ovary Syndrome,Endothelial Dysfunction
R3 T3 T5 ThemeOf Polycystic ovary syndrome,common
R4 T4 T5 ThemeOf PCOS,common
R5 T10 T8 ThemeOf PCOS,endothelial dysfunction
R6 T12 T11 ThemeOf endothelial,biomarkers
R7 T14 T11 ThemeOf visfatin,biomarkers
R8 T16 T11 ThemeOf vascular,biomarkers
R9 T18 T11 ThemeOf endothelial,biomarkers
R10 T19 T11 ThemeOf VEGF,biomarkers
R11 T20 T11 ThemeOf matrix metalloproteinase 9,biomarkers
R12 T21 T11 ThemeOf MMP-9,biomarkers
R13 T22 T11 ThemeOf PCOS,biomarkers
R14 T22 T12 ThemeOf PCOS,endothelial
R15 T24 T26 ThemeOf visfatin,concentrations
R16 T26 T27 ThemeOf concentrations,increased
R17 T29 T27 ThemeOf production,increased
R18 T30 T27 ThemeOf inflammation,increased
R19 T27 T32 CauseOf increased,increased
R20 T27 T35 CauseOf increased,related
R21 T27 T36 CauseOf increased,abnormalities
R22 T27 T39 CauseOf increased,multiple cyst formation
R23 T27 T40 CauseOf increased,follicular atresia
R24 T27 T42 CauseOf increased,anovulation
R25 T28 T27 ThemeOf VEGF,increased
R26 T28 T29 ThemeOf VEGF,production
R27 T32 T30 CauseOf increased,inflammation
R28 T34 T32 ThemeOf concentrations,increased
R29 T32 T35 CauseOf increased,related
R30 T32 T36 CauseOf increased,abnormalities
R31 T32 T38 CauseOf increased,ovarian extracellular matrix
R32 T32 T39 CauseOf increased,multiple cyst formation
R33 T32 T40 CauseOf increased,follicular atresia
R34 T32 T42 CauseOf increased,anovulation
R35 T33 T32 ThemeOf MMP-9,increased
R36 T33 T34 ThemeOf MMP-9,concentrations
R37 T34 T35 ThemeOf concentrations,related
R38 T38 T36 ThemeOf ovarian extracellular matrix,abnormalities
R39 T40 T36 ThemeOf follicular atresia,abnormalities
R40 T42 T36 ThemeOf anovulation,abnormalities

Inflammaging

Id Subject Object Predicate Lexical cue
T1 0-78 Sentence denotes Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome.
T2 79-179 Sentence denotes Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age.
T3 180-334 Sentence denotes The criteria required for the diagnosis identify various phenotypes, with different reproductive, metabolic, and cardiovascular (CV) risk characteristics.
T4 335-498 Sentence denotes Emerging evidence links adipocyte-secreted hormones as candidates in the pathogenesis of endothelial dysfunction in PCOS, independently of additional risk factors.
T5 499-737 Sentence denotes The aim of this review was to collect, analyze, and qualitatively resynthesize evidence on biomarkers of endothelial dysfunction (visfatin, vascular endothelial growth factor [VEGF], matrix metalloproteinase 9 [MMP-9]) in women with PCOS.
T6 738-1152 Sentence denotes Women with PCOS exhibit (a) increased plasma visfatin concentrations compared with controls with a similar body mass index; (b) increased VEGF production along with chronic, mild inflammation; and (c) increased MMP-9 concentrations, which might be related to either excessive CV risk or abnormalities of ovarian extracellular matrix remodeling, multiple cyst formation, follicular atresia, and chronic anovulation.
T7 1153-1266 Sentence denotes As PCOS has been associated with CV risk, early identification of endothelial dysfunction is clinically relevant.
T1 0-78 Sentence denotes Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome.
T2 79-179 Sentence denotes Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age.
T3 180-334 Sentence denotes The criteria required for the diagnosis identify various phenotypes, with different reproductive, metabolic, and cardiovascular (CV) risk characteristics.
T4 335-498 Sentence denotes Emerging evidence links adipocyte-secreted hormones as candidates in the pathogenesis of endothelial dysfunction in PCOS, independently of additional risk factors.
T5 499-737 Sentence denotes The aim of this review was to collect, analyze, and qualitatively resynthesize evidence on biomarkers of endothelial dysfunction (visfatin, vascular endothelial growth factor [VEGF], matrix metalloproteinase 9 [MMP-9]) in women with PCOS.
T6 738-1152 Sentence denotes Women with PCOS exhibit (a) increased plasma visfatin concentrations compared with controls with a similar body mass index; (b) increased VEGF production along with chronic, mild inflammation; and (c) increased MMP-9 concentrations, which might be related to either excessive CV risk or abnormalities of ovarian extracellular matrix remodeling, multiple cyst formation, follicular atresia, and chronic anovulation.
T7 1153-1266 Sentence denotes As PCOS has been associated with CV risk, early identification of endothelial dysfunction is clinically relevant.